Literature DB >> 16757076

Use of the Hayling task to measure inhibition of prepotent responses in normal aging and Alzheimer's disease.

Sylvie Belleville1, Nancie Rouleau, Martial Van der Linden.   

Abstract

This study measures the effect of Alzheimer's disease (AD) and normal aging on the inhibition of prepotent responses. AD patients, normal aged controls, and young subjects were tested with the Hayling task, which measures the ability to inhibit a semantically constrained response, and with the Stroop procedure. AD patients showed a severe deficit in both error rates and response time on the Hayling task. Inhibition was also impaired on the Stroop procedure, both when using raw performance and when using an inhibition score that controlled for reading and naming speed. Normal aged participants showed modest impairment relative to young controls on both tests. Examination of individual performance in AD patients indicated that the impairment was found in most patients on the Hayling test but in only a subgroup of patients on the Stroop test.

Entities:  

Mesh:

Year:  2006        PMID: 16757076     DOI: 10.1016/j.bandc.2006.04.006

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  24 in total

1.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

Review 2.  The elusive nature of executive functions: a review of our current understanding.

Authors:  María Beatriz Jurado; Mónica Rosselli
Journal:  Neuropsychol Rev       Date:  2007-09-05       Impact factor: 7.444

3.  The Victoria Stroop Test: Normative Data in Quebec-French Adults and Elderly.

Authors:  Marie-Pier Tremblay; Olivier Potvin; Sylvie Belleville; Nathalie Bier; Lise Gagnon; Sophie Blanchet; Nélia-Sofia Domingues; Geneviève Gaudreau; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-12-01       Impact factor: 2.813

4.  Bilingual language intrusions and other speech errors in Alzheimer's disease.

Authors:  Tamar H Gollan; Alena Stasenko; Chuchu Li; David P Salmon
Journal:  Brain Cogn       Date:  2017-07-25       Impact factor: 2.310

5.  The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment.

Authors:  Eleni Aretouli; Ozioma C Okonkwo; Jaclyn Samek; Jason Brandt
Journal:  J Int Neuropsychol Soc       Date:  2010-12-21       Impact factor: 2.892

6.  One executive function never comes alone: monitoring and its relation to working memory, reasoning, and different executive functions.

Authors:  Bettina Gathmann; Matthias Brand; Johannes Schiebener
Journal:  Cogn Process       Date:  2016-07-09

7.  Inhibitory Control Deficits in Individuals with Amnestic Mild Cognitive Impairment: a Meta-Analysis.

Authors:  Rahel Rabi; Brandon P Vasquez; Claude Alain; Lynn Hasher; Sylvie Belleville; Nicole D Anderson
Journal:  Neuropsychol Rev       Date:  2020-03-12       Impact factor: 7.444

8.  Delay and probability discounting as candidate markers for dementia: an initial investigation.

Authors:  Cutter A Lindbergh; Antonio N Puente; Joshua C Gray; James Mackillop; L Stephen Miller
Journal:  Arch Clin Neuropsychol       Date:  2014-09-18       Impact factor: 2.813

9.  A further evaluation of decision-making under risk and under ambiguity in schizophrenia.

Authors:  Guillaume Fond; Sophie Bayard; Delphine Capdevielle; Jonathan Del-Monte; Nawale Mimoun; Alexandra Macgregor; Jean-Philippe Boulenger; Marie-Christine Gely-Nargeot; Stéphane Raffard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

10.  The cognitive mechanisms underlying perspective taking between conversational partners: evidence from speakers with Alzheimer׳s disease.

Authors:  Liane Wardlow; Iva Ivanova; Tamar H Gollan
Journal:  Neuropsychologia       Date:  2014-01-24       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.